AbbVie
ABBV
$191.08
Share price
-0.70%
Change (1 day)
12.61%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Operating Margin for AbbVie (ABBV)
Operating Margin as of June 2025 (TTM): 6.31%
According to AbbVie's latest financial reports and stock price the company's current Operating Margin is 6.31%. At the end of 2024 the company had an Operating Margin of 6.60%.
Operating Margin history for AbbVie from 2011 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 6.60% | -42.67% |
| 2023 | 11.51% | -50.43% |
| 2022 | 23.21% | 0.44% |
| 2021 | 23.11% | 211.56% |
| 2020 | 7.42% | -70.71% |
| 2019 | 25.33% | 59.63% |
| 2018 | 15.87% | -42.06% |
| 2017 | 27.39% | -10.95% |
| 2016 | 30.75% | 5.79% |
| 2015 | 29.07% | 144.93% |
| 2014 | 11.87% | -58.17% |
| 2013 | 28.38% | -8.9% |
| 2012 | 31.15% | 48.13% |
| 2011 | 21.03% | -32% |
| 2010 | 30.92% | -26.13% |
| 2009 | 41.86% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 12.60% | 99.68% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 12.82% | 103.17% | 🇺🇸 USA |
 Eli Lilly LLY | 27.75% | 339.78% | 🇺🇸 USA |
 Amgen AMGN | 19.48% | 208.72% | 🇺🇸 USA |
 Gilead Sciences GILD | 23.75% | 276.39% | 🇺🇸 USA |
 Biogen BIIB | 17.85% | 182.88% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 13.32% | 111.09% | 🇬🇧 UK |
 AstraZeneca AZN | 16.07% | 154.68% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | 20.63% | 226.94% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.